An Evaluation of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates.
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Moxifloxacin/dexamethasone (Primary) ; Dexamethasone; Moxifloxacin
- Indications Bacterial infections; Ophthalmic infections
- Focus Therapeutic Use
- Sponsors Alcon
- 04 Dec 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 05 Mar 2012 Planned end date changed from 1 Mar 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.